Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louise Stone

Showing results (11-20 of 294) with videos related to

Pageof 30
Sort By:
Australian Family Physician|June 10, 2011
Explaining the unexplainable - crafting explanatory frameworks for medically unexplained symptomsLouise Stone
Nature Reviews. Urology|January 13, 2016
Kidney cancer: Programmed death ligand 1 regulation in ccRCCLouise Stone
Nature Reviews. Urology|November 11, 2015
Bladder cancer: In the driving seat - AGL loss drives tumour growthLouise Stone
Australian Family Physician|October 22, 2015
Managing medically unexplained illness in general practiceLouise Stone
Nature Reviews. Urology|April 28, 2019
Risk of urolithiasis increased with testosterone replacement therapyLouise Stone
Nature Reviews. Urology|May 20, 2018
Hypoxia-related gene panel is prognosticLouise Stone
Nature Reviews. Urology|July 13, 2022
Control of oncogenic signalling in ccRCCLouise Stone
Nature Reviews. Urology|September 14, 2016
Prostate cancer: More cycles of docetaxel improve survivalLouise Stone
Nature Reviews. Urology|June 7, 2017
Prostate cancer: Escaping enzalutamide: Malat1 contributes to resistanceLouise Stone
Nature Reviews. Urology|April 21, 2023
PROTACs for prostate cancerLouise Stone
Pageof 30

Showing results (11-20 of 294) with videos related to

Sort By:
Pageof 30
Australian Family Physician|June 10, 2011
Explaining the unexplainable - crafting explanatory frameworks for medically unexplained symptomsLouise Stone
Nature Reviews. Urology|January 13, 2016
Kidney cancer: Programmed death ligand 1 regulation in ccRCCLouise Stone
Nature Reviews. Urology|November 11, 2015
Bladder cancer: In the driving seat - AGL loss drives tumour growthLouise Stone
Australian Family Physician|October 22, 2015
Managing medically unexplained illness in general practiceLouise Stone
Nature Reviews. Urology|April 28, 2019
Risk of urolithiasis increased with testosterone replacement therapyLouise Stone
Nature Reviews. Urology|May 20, 2018
Hypoxia-related gene panel is prognosticLouise Stone
Nature Reviews. Urology|July 13, 2022
Control of oncogenic signalling in ccRCCLouise Stone
Nature Reviews. Urology|September 14, 2016
Prostate cancer: More cycles of docetaxel improve survivalLouise Stone
Nature Reviews. Urology|June 7, 2017
Prostate cancer: Escaping enzalutamide: Malat1 contributes to resistanceLouise Stone
Nature Reviews. Urology|April 21, 2023
PROTACs for prostate cancerLouise Stone
Pageof 30